Updated on 8 September 2026 to replace unsupported medical and economic claims with data from the ICMR-backed national study, the Health Ministry and WHO.
India is living with a very large and uneven diabetes burden. A national study backed by the Indian Council of Medical Research estimated that 101 million people in the country had diabetes in 2021, while another 136 million had prediabetes.
The figures came from the ICMR–India Diabetes study, published in The Lancet Diabetes & Endocrinology in 2023. Researchers analysed data from 113,043 adults across every state and union territory. They estimated a national diabetes prevalence of 11.4% and a prediabetes prevalence of 15.3%.
These are population estimates, not a count of people individually diagnosed. They nevertheless show the scale of the public-health challenge and the number of people who may require screening, medical advice and continuing care.
The risk is not the same everywhere
The national average hides wide regional differences. The study found that several more-developed states and urban populations already had high diabetes prevalence, while some states with lower current prevalence had substantial levels of prediabetes. That combination suggests the future burden may rise unless prevention and early detection improve.
The research also identified high rates of hypertension, generalised obesity and abdominal obesity. These conditions can overlap with diabetes risk and make long-term care more complex. The result is not only pressure on hospitals; it is an ongoing demand for primary care, affordable tests, reliable medicines and patient education close to where people live.
Why early diagnosis matters
Diabetes can damage the heart, blood vessels, eyes, kidneys and nerves when it is not diagnosed or adequately controlled. The World Health Organization says early diagnosis can be achieved through relatively inexpensive blood-glucose testing. Treatment aims to control glucose and other cardiovascular risk factors and may include medication as well as changes in diet and physical activity.
That distinction is important. A healthy diet can help prevent or manage type 2 diabetes, but food should not be described as a replacement for prescribed treatment. People with type 1 diabetes require insulin, and people with any form of diabetes should not stop or alter medication without qualified medical advice.
India’s National Programme for Prevention and Control of Non-Communicable Diseases supports population-based screening for common NCDs, including diabetes and hypertension, for people aged 30 and above through the public-health system. Access and follow-up can still vary by location, making implementation as important as the existence of the programme.
Better food environments, without misleading labels
Public places can make healthier choices easier by offering water, unsweetened drinks, vegetables, pulses, whole grains and clearly labelled portions. Railway stations, airports, schools, workplaces and government canteens can also improve nutrition information and reduce the routine promotion of products high in free sugars or heavily refined carbohydrates.
However, a universal “diabetic meal” label can be misleading. Individual needs differ according to medication, activity, other health conditions and the timing of meals. A better approach is transparent ingredient and nutrition information combined with professional, personalised advice.
News Trust India’s report on food-safety action involving quick-commerce platforms provides related context on why food information and regulatory oversight matter.
What a stronger response looks like
The evidence points to four priorities: accessible screening, dependable follow-up, affordable essential treatment and prevention tailored to local diets and living conditions. Public campaigns should explain symptoms and risk factors without blaming patients. Health facilities also need systems that help people continue care rather than receiving a single test with no follow-up.
For individuals, official advice is safer than internet “cure” claims. Anyone concerned about symptoms or risk should seek testing and guidance from a qualified health professional. This report provides general information and is not a diagnosis or treatment plan.
India’s diabetes burden cannot be solved by medicine or diet alone. It requires a primary-care system that detects disease early, supports long-term management and makes healthier choices more practical for millions of people.
Sources
ICMR–INDIAB study in The Lancet Diabetes & Endocrinology; PubMed record; Ministry of Health response on the study and NCD programme; WHO diabetes fact sheet
This report was prepared with AI assistance and reviewed, fact-checked and approved by the News Trust India editorial team.
About The Author
